logo
HDFC Life shares in focus after Q1 profit jumps 14% YoY to Rs 546 crore; net premium income up 16%

HDFC Life shares in focus after Q1 profit jumps 14% YoY to Rs 546 crore; net premium income up 16%

Economic Times10 hours ago
The net premium income fell sharply by 39% when compared to the Rs 23,766 crore achieved in the January-March quarter of FY25.
Synopsis HDFC Life Insurance Company reported a 14% YoY jump in Q1 FY26 profit to Rs 546 crore and a 16% rise in net premium income. Strong gains in market share, persistency, and new business value reflect solid operational momentum despite a sequential dip in topline. HDFC Life Insurance Company shares are in focus today after the firm reported a 14% year-on-year (YoY) growth in its standalone net profit at Rs 546 crore for the first quarter of fiscal year 2026 (Q1 FY26). This compares to Rs 478 crore posted in the year-ago period.
ADVERTISEMENT
The company's net premium income rose 16% to Rs 14,466 crore versus Rs 12,510 crore recorded in the same quarter last year. On a sequential basis, profit after tax (PAT) was 15% higher than the Rs 477 crore reported in Q4 FY25.
However, it's notable that the net premium income fell sharply by 39% when compared to the Rs 23,766 crore achieved in the January-March quarter of FY25.
- Topline Growth: Individual Annualised Premium Equivalent (APE) grew by 12.5% YoY, translating into a robust 2-year CAGR of 21%.- Market Share: The company outperformed the overall industry and private sector, resulting in a 70 bps increase in our market share at the overall level to 12.1%, a new milestone for us, and a 40 bps gain within the private sector, taking our share to 17.5%, the exchange filing said.
ADVERTISEMENT
- Value of New Business (VNB) for Q1 FY26 stood at Rs 809 crore, a growth of 12.7% YoY and a 2-year CAGR of 15% with new business margins improving to 25.1%.
- Assets under Management (AUM) stood at Rs 3,55,897 lakh crore as on June 30, 2025, an increase of 15% YoY.
ADVERTISEMENT - Persistency: Persistency metrics remained healthy, with 13th and 61st month persistency at 86% and 64% respectively. 61st month persistency improved across cohorts, supported by stronger retention in long-term savings products.- Embedded Value (EV) increased to Rs 58,355 crore, with an operating RoEV of 16.3% on a rolling 12-month basis.
ADVERTISEMENT
Commenting on the company's Q1 earnings, Vibha Padalkar, Managing Director and CEO of HDFC Life, said that the first quarter began on a strong note, with healthy growth across topline, value of new business, and steady margins."We outperformed both the overall industry and the private sector, resulting in a 70 bps increase in our market share at the overall level to 12.1%, a new milestone for us, and a 40 bps gain within the private sector, taking our share to 17.5%. Moreover, over 70% of new customers acquired in Q1 were first-time buyers with HDFC Life, underscoring our customer acquisition strength and deepening presence across Tier 1, 2, and 3 markets," she said.
ADVERTISEMENT
Also read: Hero MotoCorp among 6 stocks with White Marubozu Pattern on July 15
"While the external environment remains dynamic, our fundamentals have held strong, anchored in a balanced product mix, a diversified distribution footprint, and a consistent focus on innovation, customer centricity and disciplined execution. Our aspiration is to continue to outpace industry growth whilst sustaining our position as a market leader amongst the top 3 in India,' she further added.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
(You can now subscribe to our ETMarkets WhatsApp channel)
Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share
Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained
Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms
Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips
L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first?
Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more
SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders
API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading
Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains
Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains
NEXT STORY
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Anthem Biosciences IPO allotment on July 17: Know how to check status online via PAN
Anthem Biosciences IPO allotment on July 17: Know how to check status online via PAN

Indian Express

time27 minutes ago

  • Indian Express

Anthem Biosciences IPO allotment on July 17: Know how to check status online via PAN

Anthem Biosciences IPO: Following the close of the subscription of initial public offering (IPO) of Anthem Biosciences Limited, all eyes of the investors will now be on the finalisation of the allotment of shares. The Anthem Biosciences IPO allotment will take place tomorrow i.e., July 17. The Anthem Biosciences IPO subscription was opened on July 14 (Monday) and closed on July 16 (Wednesday). On Wednesday, the initial share sale received bids for 2,81,42,36,230 shares, as against 4,40,70,682 shares on offer, according to NSE data. The category for non-institutional investors fetched 42.35 times subscription, while the quota for retail individual investors (RIIs) got subscribed 5.63 times. Qualified institutional buyers (QIBs) part received 182.65 times subscription. Anthem Biosciences IPO has fixed the price band at Rs 540 to Rs 570 per equity share. According to the details available, the Anthem Biosciences IPO is slated to be finalised on July 17. The allotment status of Anthem Biosciences IPO will be released online on the official website of the Registrar – KFin Technologies Limited. Additionally, the allotment status will also be made available on the official websites of the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). – – –

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store